Portfolio Investments
Madryn invests in innovative and transformative companies that are driving the future of the healthcare industry
At Madryn, we are much more than a provider of capital. We are business builders and thoughtful strategic partners that possess extensive healthcare industry experience, knowledge and expertise. We take pride in collaborating and working alongside management teams to help them scale their companies, navigate operational challenges, and support their long-term growth.
SomaLogic is a privately held proteomics company focused on the discovery, development and commercialization of life science research tools, diagnostic products and therapeutic products for the life sciences and pharmaceutical industries. SomaLogic’s mission is to use its proprietary modified aptamer-based proteomic technologies to develop a wide range of enhanced protein-analysis tools and reagents for the life sciences community to facilitate biomarker discovery and validation for diagnostic and therapeutic applications, and to develop and commercialize clinical diagnostic products that will improve the delivery of health care by offering timely and accurate diagnostic information to physicians and their patients.